Transcendental Medication WRITTEN BY DAMON ORION WEDNESDAY, 22 JULY 2009 From: http://www.gtweekly.com/20090722460031/good-times/covers/transcendental-medication (cover article image) A look inside the …
We submitted to FDA a protocol that would allow therapist from our MDMA/PTSD research teams to take MDMA in a clinical-therapeutic setting. We believe that it will benefit therapist who will be working …
The basic balance sheet information for FY 2008-2009 is presented below. For a complete discussion of MAPS 2008-2009 fiscal year see Rick Doblin's financial report in MAPS Bulletin
Over the past several weeks, MAPS clinical research team members Valerie Mojeiko, Director of Operations and Clinical Research Associate, and Joshua Sonstroem, Information and Technology Specialist and …
Swiss LSD/End-of-Life Study Receives $25,695 donation: On April 8, Robert Barnhart generously donated $25,695 to MAPS for our Swiss LSD/End-of-Life study. Robert has now donated over $100,000 to this study, …
Investigator: David E. Nichols, PhD Purdue University – West Lafayette, IN Contact: David E. Nicholas Sponsor: Heffter, Promind Laboratory research, no human or animal subjects. It is well known …
MAPS Clinical research team members Valerie Mojeiko and Joshua Sonstroem are currently out “in the field” meeting with MAPS researchers around the world on a several week- monitoring trip. …
by Peter Bebergal Published in Search Magazine in the January-February 2009 issue Originally appearing here. Is there such a thing as a core, common mystical experience? Until 2006, John Hayes, a psychologist …
On December 29, 2008, Jan Irvin uploaded a fantastic interview with MAPS President Rick Doblin PhD. The podcast is available on the Gnostic Media website. Jan has two other podcasts that should interest …
Investigator: Peter Gasser MD Sponsor: MAPS Contact: Peter Gasser, MD This research will study the safety and efficacy of LSD-assisted psychotherapy in reducing anxiety arising from diagnosis with a serious …
Investigator: R. Andrew Sewell MD Contact: Sponsor: MAPS Inspired by reports from the cluster headache community that ingestion of seeds containing LSA (Hawaiian baby woodrose, morning glory, Rivea corymbosa) …
On November 25, 2008, Dr. Peter Gasser, the Principal Investigator (PI) for the MAPS-sponsored LSD/end-of-life anxiety study, issued the first Annual Report discussing the progress we’ve made in …